EP 80318: A novel CD36 ligand with hypocholesterolemic and anti-atherosclerotic properties in Apoe-null mice

被引：0
|
作者：
Bessi, Valerie L. [1 ]
Bujold, Kim [1 ]
Marleau, Sylvie [1 ]
Ong, Huy [1 ]
机构：
[1] Univ Montreal, Montreal, PQ H3C 3J7, Canada
来源：
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 2007年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E124 / E124
页数：1
相关论文
共 18 条
  • [1] The anti-atherosclerotic effects of EP 80317, a selective ligand of CD36, are associated with anti-inflammatory actions
    Harb, D.
    Ong, H.
    Marleau, S.
    [J]. CANADIAN JOURNAL OF CARDIOLOGY, 2007, 23 : 184C - 184C
  • [2] THE ANTI-ATHEROSCLEROTIC EFFECT OF EP80317, A SELECTIVE LIGAND OF CD36, IS ASSOCIATED WITH ANTI-INFLAMMATORY ACTIONS
    Ong, H.
    Harb, D.
    Febbraio, M.
    Marleau, S.
    [J]. ATHEROSCLEROSIS SUPPLEMENTS, 2008, 9 (01) : 166 - 166
  • [3] ApoE-Null mice lacking CD36/FAT are protected against neointimal hyperplasia and have an altered autoimmune response to hyperlipidemia
    Pappan, Loretta K.
    Oldenborg, Anna
    Coleman, Trey
    Semenkovich, Clay F.
    Moore, Kathryn J.
    Frazier, William A.
    [J]. CIRCULATION, 2006, 114 (18) : 294 - 294
  • [4] CD36 deficient stem cells confer atheroprotection to ApoE null mice
    Febbraio, M
    Guy, E
    Silverstein, RL
    [J]. CIRCULATION, 2002, 106 (19) : 152 - 152
  • [5] Skeletal inflammation and attenuation of Wnt signaling, Wnt ligand expression, and bone formation in atherosclerotic ApoE-null mice
    Liu, Yu
    Almeida, Maria
    Weinstein, Robert S.
    O'Brien, Charles A.
    Manolagas, Stavros C.
    Jilka, Robert L.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2016, 310 (09): : E762 - E773
  • [6] EP80317, a selective ligand of the CD36 scavenger receptor, reduces 111In-labeled macrophages trafficking to atherosclerotic lesions in apoE-deficient mice
    Harb, D
    Febbraio, M
    Ong, H
    Marleau, S
    [J]. FASEB JOURNAL, 2006, 20 (04): : A666 - A666
  • [7] Systemic trail delivery shows anti-atherosclerotic activity in diabetic apolipoprotein E-Null (ApoE) mice
    Candido, R.
    Secchiero, P.
    Toffoli, B.
    Corallini, F.
    Zacchigna, S.
    Manca, E.
    Caroli, E.
    Da Col, P.
    Carretta, R.
    Giacca, M.
    Zauli, G.
    Fabris, B.
    [J]. DIABETOLOGIA, 2006, 49 : 736 - 737
  • [8] Continued inhibition of atherosclerotic lesion development in long term Western diet fed CD36°/apoE° mice
    Guy, Ella
    Kuchibhotla, Sai
    Silverstein, Roy
    Febbraio, Maria
    [J]. ATHEROSCLEROSIS, 2007, 192 (01) : 123 - 130
  • [9] Growth Hormone-Releasing Peptides as anti-atherosclerotic agents, inhibit macrophages trafficking to atherosclerotic lesions through CD36 but not through the ghrelin receptor
    Harb, D
    Febbraio, M
    Ong, H
    Marleau, S
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (05) : E98 - E98
  • [10] EP 80317, a CD36 selective ligand, promotes reverse cholesterol transport in apolipoprotein E-deficient mice
    Bujold, Kim
    Mellal, Katia
    Zoccal, Karina F.
    Rhainds, David
    Brissette, Louise
    Febbraio, Maria
    Marleau, Sylvie
    Ong, Huy
    [J]. ATHEROSCLEROSIS, 2013, 229 (02) : 408 - 414
12